Skip to main content
Clinical Trials/JPRN-UMIN000029351
JPRN-UMIN000029351
Recruiting
未知

Multicenter retrospective study of efficacy of the combination of cetuximab and paclitaxel in patients with recurrent and/or metastatic oral squamous cell carcinoma - Retrospective study of the efficacy of the combination of cetuximab and paclitaxel

agasaki university0 sites50 target enrollmentSeptember 29, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Recurrent and/or metastatic oral squamous cell carcinoma
Sponsor
agasaki university
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 29, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
agasaki university

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Before December 2012 there is a treatment history with Cetuximab. 2\. Besides oral cancer, it has serious complications affecting life prognosis 3\. Other patients whose research managers judged inappropriate as subjects.

Outcomes

Primary Outcomes

Not specified

Similar Trials